Dow Up 0.11% Nasdaq Up 0.50%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
10.09 Aug 29, 4:00PM EDT
|Pre-Market : 10.10 Up 0.01 (0.10%) 8:55AM EDT - Nasdaq Real Time Price
Prev Close:10.09
Open:N/A
Bid:10.02 x 100
Ask:10.10 x 500
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:N/A - N/A
52wk Range:7.38 - 10.21
Volume:600
Avg Vol (3m):2,284,500
Market Cap:1.62B
P/E (ttm):5.81
EPS (ttm):1.74
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLI 0.00%1.62B
AMGN105.87B
SGEN5.43B
XOMA469.00M

Key Statistics

Forward P/E (1 yr):4.50
P/S (ttm):3.69
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :1.98
Quarterly EPS Est (Sep-14) :0.50
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback